The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Avants, S. K.
* Articles by Kosten, T. R.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Avants, S. K.
* Articles by Kosten, T. R.
Related Collections
* Cocaine
* Opioids
* Behavior Therapy
* Cognitive Therapy
* Other Somatic Therapy
Am J Psychiatry 156:27-33, January 1999
©Copyright 1999 American Psychiatric Association


Regular Article

Day Treatment Versus Enhanced Standard Methadone Services for Opioid-Dependent Patients: A Comparison of Clinical Efficacy and Cost

S. Kelly Avants, Ph.D., Arthur Margolin, Ph.D., Jody L. Sindelar, Ph.D., Bruce J. Rounsaville, M.D., Richard Schottenfeld, M.D., Susan Stine, M.D., Ph.D., Ned L. Cooney, Ph.D., Robert A. Rosenheck, M.D., Shou-Hua Li, Ph.D., and Thomas R. Kosten, M.D.

OBJECTIVE: This study examined the differential efficacy and relative costs of two intensities of adjunctive psychosocial services—a day treatment program and enhanced standard care—for the treatment of opioid-dependent patients maintained on methadone hydrochloride. METHOD: A 12-week randomized clinical trial with 6-month follow-up was conducted in a community-based methadone maintenance program. Of the 308 patients who met inclusion criteria, 291 began treatment (day treatment program: N=145; enhanced standard care: N=146), and 237 completed treatment (82% of those assigned to the day treatment program and 81% of those receiving enhanced standard care). Two hundred twenty of the patients participated in the 6-month follow-up (75% of those in the day treatment program and 73% of those in enhanced standard care provided a follow-up urine sample for screening). Both interventions were 12 weeks in duration, manual-guided, and provided by master's-level clinicians. The day treatment was an intensive, 25-hour-per-week program. The enhanced standard care was standard methadone maintenance plus a weekly skills training group and referral to on- and off-site services. Outcome measures included twice weekly urine toxicology screens, severity of addiction-related problems, prevalence of HIV risk behaviors, and program costs. RESULTS: Although the cost of the day treatment program was significantly higher, there was no significant difference in the two groups' use of either opiates or cocaine. Over the course of treatment, drug use, drug-related problems, and HIV risk behaviors decreased significantly for patients assigned to both treatment intensities. Improvements were maintained at follow-up. CONCLUSIONS: Providing an intensive day treatment program to unemployed, inner-city methadone patients was not cost-effective relative to a program of enhanced methadone maintenance services, which produced comparable outcomes at less than half the cost.




This article has been cited by other articles:


Home page
Psychiatr. Bull.Home page
R. Joseph and H. F. Moselhy
National survey of methadone prescribing for maintenance treatment: 'opiophobia' among substance misuse services?
Psychiatr. Bull., December 1, 2005; 29(12): 459 - 461.
[Abstract] [Full Text] [PDF]


Home page
JOURNAL OF CORRECTIONAL HEALTH CAREHome page
E. M. Howell, R. B. Greifinger, and A. S. Sommers
What Is Known About the Cost-Effectiveness of Health Services for Returning Prisoners?
Journal of Correctional Health Care, April 1, 2004; 10(3): 399 - 436.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
M. J. Krantz and P. S. Mehler
Treating Opioid Dependence: Growing Implications for Primary Care
Arch Intern Med, February 9, 2004; 164(3): 277 - 288.
[Abstract] [Full Text] [PDF]


Home page
FocusHome page
A. I. Leshner
Science Is Revolutionizing Our View of Addiction--and What to Do About It
Focus, April 1, 2003; 1(2): 194 - 195.
[Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
K. M. Carroll and B. J. Rounsaville
Bridging the Gap: A Hybrid Model to Link Efficacy and Effectiveness Research in Substance Abuse Treatment
Psychiatr Serv, March 1, 2003; 54(3): 333 - 339.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
B. J. Rounsaville and T. R. Kosten
Treatment for Opioid Dependence: Quality and Access
JAMA, March 8, 2000; 283(10): 1337 - 1339.
[Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1999 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org